Congress or a federal agency will write ibogaine heart-monitoring requirements into actual legal language by mid-August 2026. This is much less likely than FDA guidance alone because Congress moves slowly and there's no emergency forcing the issue.
The resolve date of August 13, 2026 is only ~3 months away. Legislative language requires bill introduction, committee markup, and passage; regulatory language requires notice-and-comment or at minimum formal agency publication. Neither process moves this fast absent a declared public health emergency. The underlying premise—that cardiac safety data has reached critical mass—is plausible, but the timeline is implausibly short for 'formal codification.' Informal guidance or IND clinical holds are more likely within this window but do not satisfy the resolution criterion. Confidence sharply reduced.